Biotech

JointStem: A Road Closed by Korea’s MFDS, Now Opening in the United States

By Lee Sang-kiAsiaN reporter, former president of the Korea Journalists Association SEOUL: Nature Cell, a leading Korean biotech company, is accelerating its entry into the U.S. market with its stem cell therapy, JointStem. On the surface, this is a global expansion strategy, but beneath it lies a stark reality: the…

Read More »